HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Liver fat, visceral adiposity, and sleep disturbances contribute to the development of insulin resistance and glucose intolerance in nondiabetic dialysis patients.

Abstract
Hemodialysis patients exhibit insulin resistance (IR) in target organs such as liver, muscles, and adipose tissue. The aim of this study was to identify contributors to IR and to develop a model for predicting glucose intolerance in nondiabetic hemodialysis patients. After a 2-h, 75-g oral glucose tolerance test (OGTT), 34 hemodialysis patients were divided into groups with normal (NGT) and impaired glucose tolerance (IGT). Indices of insulin sensitivity were derived from OGTT data. Measurements included liver and muscle fat infiltration and central adiposity by computed tomography scans, body composition by dual energy X-ray absorptiometer, sleep quality by full polysomnography, and functional capacity and quality of life (QoL) by a battery of exercise tests and questionnaires. Cut-off points, as well as sensitivity and specificity calculations were based on IR (insulin sensitivity index by Matsuda) using a receiver operator characteristics (ROC) curve analysis. Fifteen patients were assigned to the IGT, and 19 subjects to the NGT group. Intrahepatic fat content and visceral adiposity were significantly higher in the IGT group. IR indices strongly correlated with sleep disturbances, visceral adiposity, functional capacity, and QoL. Visceral adiposity, O2 desaturation during sleep, intrahepatic fat content, and QoL score fitted into the model for predicting glucose intolerance. A ROC curve analysis identified an intrahepatic fat content of > 3.97% (sensitivity, 100; specificity, 35.7) as the best cutoff point for predicting IR. Visceral and intrahepatic fat content, as well as QoL and sleep seemed to be involved at some point in the development of glucose intolerance in hemodialysis patients. Means of reducing fat depots in the liver and splachnic area might prove promising in combating IR and cardiovascular risk in hemodialysis patients.
AuthorsGiorgos K Sakkas, Christina Karatzaferi, Elias Zintzaras, Christoforos D Giannaki, Vassilios Liakopoulos, Eleftherios Lavdas, Eleni Damani, Nikos Liakos, Ioannis Fezoulidis, Yiannis Koutedakis, Ioannis Stefanidis
JournalAmerican journal of physiology. Regulatory, integrative and comparative physiology (Am J Physiol Regul Integr Comp Physiol) Vol. 295 Issue 6 Pg. R1721-9 (Dec 2008) ISSN: 0363-6119 [Print] United States
PMID18832089 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Topics
  • Absorptiometry, Photon
  • Adiposity
  • Adolescent
  • Adult
  • Aged
  • Female
  • Glucose Intolerance (etiology, physiopathology)
  • Glucose Tolerance Test
  • Humans
  • Insulin Resistance
  • Intra-Abdominal Fat (diagnostic imaging, physiopathology)
  • Liver (diagnostic imaging, physiopathology)
  • Male
  • Middle Aged
  • Models, Biological
  • Muscle, Skeletal (physiopathology)
  • Nutritional Status
  • Polysomnography
  • Predictive Value of Tests
  • Quality of Life
  • ROC Curve
  • Renal Dialysis
  • Risk Assessment
  • Risk Factors
  • Sleep Wake Disorders (complications, physiopathology)
  • Surveys and Questionnaires
  • Tomography, X-Ray Computed
  • Young Adult

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: